TENOR CAPITAL MANAGEMENT Co. L.P. bought a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 635,399 shares of the company’s stock, valued at approximately $11,717,000.
Several other large investors have also added to or reduced their stakes in the business. Parallax Volatility Advisers L.P. acquired a new position in Translational Development Acquisition during the fourth quarter worth $929,000. Wealthspring Capital LLC acquired a new stake in Translational Development Acquisition in the fourth quarter valued at $1,095,000. Yakira Capital Management Inc. acquired a new stake in Translational Development Acquisition in the fourth quarter valued at $1,106,000. Warberg Asset Management LLC acquired a new stake in Translational Development Acquisition in the fourth quarter valued at $1,373,000. Finally, Centiva Capital LP acquired a new stake in Translational Development Acquisition in the fourth quarter valued at $1,844,000.
Translational Development Acquisition Price Performance
Shares of TDACU stock opened at $10.25 on Friday. The company has a fifty day moving average price of $10.19. Translational Development Acquisition Corp. has a one year low of $10.00 and a one year high of $10.30.
Translational Development Acquisition Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Featured Articles
- Five stocks we like better than Translational Development Acquisition
- Health Care Stocks Explained: Why You Might Want to Invest
- Top 4 ETFs for China Exposure After Tariff Relief
- Insider Trading – What You Need to Know
- Build a Complete Bond Portfolio With These 4 ETFs
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 05/12 – 05/16
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.